Trevena, Inc. Appoints Mark Corrigan, M.D. to Board of Directors
has been appointed to the Company’s Board of Directors, effective July 18 2023.
- has been appointed to the Company’s Board of Directors, effective July 18 2023.
- “We are pleased to welcome Mark to Trevena’s Board of Directors,” said Carrie Bourdow, Trevena’s President and CEO.
- “Mark has over 30 years of experience in the life sciences industry and broad neuroscience expertise.
- Dr. Corrigan serves as Chairman of the Board of Directors of Elios Therapeutics and as a member of the Board of Directors of Nabriva Therapeutics and Wave Life Sciences.